NCT00070837View on ClinicalTrials.gov

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

October 31, 2004

Conditions
Prostatic Neoplasms
Interventions
DRUG

MLN2704 (DM1 conjugated monoclonal antibody MLN591)

Trial Locations (4)

10021

Memorial Sloan-Kettering Cancer Center, New York

Weill Medical College of Cornell University/ New York Presbyterian Hospital, New York

27710

Duke University Medical Center, Box 3532, Durham

44195

Cleveland Clinic, Taussig Cancer Center, Cleveland

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY